Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Rothman

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Review of Anticancer Therapy|January 25, 2026
Use of Razoxane as a radiosensitizer for the treatment of soft tissue sarcomasJohn Rothman
Expert Review of Vaccines|May 11, 2013
Live-attenuated Listeria-based immunotherapyJohn Rothman, Yvonne Paterson
Vaccine|April 25, 2009
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervixPaulo Cesar Maciag, Sinisa Radulovic, John Rothman
Clinical Therapeutics|September 8, 2019
Effect of L1-79 on Core Symptoms of Autism Spectrum Disorder: A Case SeriesJohn Rothman, Eric J Bartky, Francis Peter Halas
Journal of Oncology|April 7, 2012
Lm-LLO-Based Immunotherapies and HPV-Associated DiseaseAnu Wallecha, Chris French, Robert Petit, et al.
Journal for Immunotherapy of Cancer|May 16, 2014
Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapyMikayel Mkrtichyan, Namju Chong, Rasha Abu Eid, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2012
Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancerRaquibul Hannan, Huagang Zhang, Anu Wallecha, et al.
Journal of Translational Medicine|November 7, 2012
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapiesAdrian Bot, Mark Ahn, Marnix Bosch, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Review of Anticancer Therapy|January 25, 2026
Use of Razoxane as a radiosensitizer for the treatment of soft tissue sarcomasJohn Rothman
Expert Review of Vaccines|May 11, 2013
Live-attenuated Listeria-based immunotherapyJohn Rothman, Yvonne Paterson
Vaccine|April 25, 2009
The first clinical use of a live-attenuated Listeria monocytogenes vaccine: a Phase I safety study of Lm-LLO-E7 in patients with advanced carcinoma of the cervixPaulo Cesar Maciag, Sinisa Radulovic, John Rothman
Clinical Therapeutics|September 8, 2019
Effect of L1-79 on Core Symptoms of Autism Spectrum Disorder: A Case SeriesJohn Rothman, Eric J Bartky, Francis Peter Halas
Journal of Oncology|April 7, 2012
Lm-LLO-Based Immunotherapies and HPV-Associated DiseaseAnu Wallecha, Chris French, Robert Petit, et al.
Journal for Immunotherapy of Cancer|May 16, 2014
Anti-PD-1 antibody significantly increases therapeutic efficacy of Listeria monocytogenes (Lm)-LLO immunotherapyMikayel Mkrtichyan, Namju Chong, Rasha Abu Eid, et al.
Cancer Immunology, Immunotherapy : CII|May 31, 2012
Combined immunotherapy with Listeria monocytogenes-based PSA vaccine and radiation therapy leads to a therapeutic response in a murine model of prostate cancerRaquibul Hannan, Huagang Zhang, Anu Wallecha, et al.
Journal of Translational Medicine|November 7, 2012
A novel series of conferences tackling the hurdles confronting the translation of novel cancer immunotherapiesAdrian Bot, Mark Ahn, Marnix Bosch, et al.
Pageof 1